Access from your Desktop on April 24
A single integrated device, MouthLabTM and cloud-based proprietary mobile application that is used to create a unique ‘biosignature’, composed of multiple digital biomarkers that intelligently reflects an individual’s true health; we call it Aidar COVIDTM. Our transformative rapid health assessment device, MouthLab, a non-invasive, at home, rapid health assessment device measures 10+ vital health parameters, such as oral temperature (TEMP), blood pressure (BP), respiratory rate (RR), respiratory flow cycle morphology (RFM), pulse rate (PR), three-lead electrocardiography (ECG), functional oxygen saturation of arterial hemoglobin (SpO2), heart rate (HR), heart rate variability (HRV), spirometer (SPIRO) or lung functions (FEV1, FVC, FEV1/FVC, PEF) and voice in just 30 seconds.
Our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinters to be the most versatile, powerful and easy-to-use bioprinters on the market.
BioSculpture Technology (aka BST)
Commercial stage medical device company developing a disruptive minimally invasive treatment of type 2 diabetes and obesity.
The first, drug-free and smart-technology innovation that uses a proprietary cooling ComfortBand to naturally trigger a neural network response in the brain, which quiets the Racing Mind and helps you to sleep.
Commercialising it’s IKOr technology platform which is initially focussed on providing real-time pressure, temperature and flow measurements through its IKOs micro-catheter for suspected heart attack patients.
Surgical instrumentation that enable users to perform surgical tasks consistently in hard to reach locations
Grace Wellness Products
IoT orthopedic rehabilitation device
Chief Executive Officer
Ibex Medical Analytics
AI-driven computational pathology cancer diagnosis system
A digital health-medical device combination product to be used at home for secure opioid storage, safe disposal, and active control dispensing with designs to treat the underlying causes of addiction and offer harm reduction technologies.
Device to non-invasively detect and monitor blood borne diseases in vivo, without taking blood
Cofounder & Chairman
Developing a rapid hand disinfection system to reduce healthcare associated infections (HAIs) using its proprietary, patented thinSpray technology and antiseptic LVNX-001. There is an unmet need for a hand hygiene solution that takes no more than 3-5 seconds, leaves hands dry, facilitates hand health, is portable to optimize workflow around the patient, and is effective against the pathogen Clostridium difficile, a leading cause of HAIs in hospitals.
President & Co-Founder
Wearable wireless vital signs monitoring solutions for medical and consumer applications
Chief Executive Officer
Digital medical device that aids in the diagnosis of Acute Compartment Syndrome
Director, Clinical Affairs & Business Development
Game-based rehabilitation devices and exercises for patients with neurological, central nervous system, and musculoskeletal injuries such as stroke
Co-founder and CEO
Developing a novel medical device to make caesarean delivery a safer and more superior surgery.
Founder & CEO
Developing an optical-based, non-invasive, chemicals and ionizing radiation free, medical imaging technology to provide early diagnosis, screening, and monitoring of deep tissue pathological conditions.
Developed QEV-817, a combined opioid and respiratory stimulant oral drug, to safely treat pain with reduce risk of respiratory depression and abuse.
Developing a robust, hands free, automatic and low cost Urine Output monitoring device for the ICU, assisting in AKI detection and prevention.
A mobile app controlled wearable device for the treatment of moderate to severe pain.
A cloud-connected vital signs monitoring system that rescues the under-monitored patients around the world.
Cerebral embolic protection for transcatheter aortic valve replacement (TAVR), cardiovascular percutaneous interventions and surgical procedures
AI-powered platform for the diagnosis and analysis of brain aneurysms
President & CEO
Voxello develops pioneering technology providing severely impaired patients the ability to communicate with caregivers and family effectively. Voxello developed the noddle® and noddle-chat to reduce adverse events, achieve better outcomes, and improve patient satisfaction while returning a sizable ROI to the hospital. Using any voluntary gesture such as a tongue click or minimal movement such as a head nod, a patient can access the nurse call and the noddle-chat, which is a speech generation device to communicate.
More companies coming soon!